A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations

2002

Schaefer, 2006, Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders, Genet Med, 8, 549, 10.1097/01.gim.0000237789.98842.f1

Wittenberger, 2007, The FMR1 premutation and reproduction, Fertil Steril, 87, 456, 10.1016/j.fertnstert.2006.09.004

Jacquemont, 2007, Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1, Lancet Neurol, 6, 45, 10.1016/S1474-4422(06)70676-7

Geva, 2000, The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families, Genet Test, 4, 289, 10.1089/10906570050501524

Pesso, 2000, Screening for fragile X syndrome in women of reproductive age, Prenatal Diag, 20, 611, 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M

Toledano-Alhadef, 2001, Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel, Am J Hum Genet, 69, 351, 10.1086/321974

Drasinover, 2000, Increased transmission of intermediate alleles of the FMR1 gene compared with normal alleles among female heterozygotes, Am J Med Genet, 93, 155, 10.1002/1096-8628(20000717)93:2<155::AID-AJMG13>3.0.CO;2-G

Rousseau, 1995, Prevalence of carriers of premutation-size alleles of the FMRI gene–and implications for the population genetics of the fragile X syndrome, Am J Hum Genet, 57, 1006

Ryynanen, 1999, Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies, Eur J Hum Genet, 7, 212, 10.1038/sj.ejhg.5200285

Dawson, 1995, Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots, Biochem Mol Med, 56, 63, 10.1006/bmme.1995.1057

Dombrowski, 2002, Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles, Hum Mol Genet, 11, 371, 10.1093/hmg/11.4.371

de Vries, 1997, Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group, Am J Hum Genet, 61, 660, 10.1086/515496

Jacobs, 1993, Population studies of the fragile X: a molecular approach, J Med Genet, 30, 454, 10.1136/jmg.30.6.454

Turner, 1996, Prevalence of fragile X syndrome, Am J Med Genet, 64, 196, 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G

Crawford, 2002, Prevalence of the fragile X syndrome in African-Americans, Am J Med Genet, 110, 226, 10.1002/ajmg.10427

Youings, 2000, FRAXA and FRAXE: the results of a five year survey, J Med Genet, 37, 415, 10.1136/jmg.37.6.415

Crawford, 2001, FMR1 and the fragile X syndrome: human genome epidemiology review, Genet Med, 3, 359, 10.1097/00125817-200109000-00006

Sherman, 2002, Epidemiology

Song, 2003, Screening for fragile X syndrome: a literature review and modelling study, Health Technol Assess, 7, 1, 10.3310/hta7160

Bailey, 2006, Changing perspectives on the benefits of newborn screening, Ment Retard Dev Disabil Res Rev, 12, 270, 10.1002/mrdd.20119

Bailey, 2005, Newborn screening for developmental disabilities: reframing presumptive benefit, Am J Public Health, 95, 1889, 10.2105/AJPH.2004.051110

Bailey, 2004, Newborn screening for fragil6e X syndrome, Ment Retard Dev Disabil Res Rev, 10, 3, 10.1002/mrdd.20002

Brown, 1996, Prenatal diagnosis and carrier screening for fragile X by PCR, Am J Med Genet, 64, 191, 10.1002/(SICI)1096-8628(19960712)64:1<191::AID-AJMG34>3.0.CO;2-G

Haddad, 1996, A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males, Hum Genet, 97, 808, 10.1007/BF02346194

Hamdan, 1997, Automated detection of trinucleotide repeats in fragile X syndrome, Mol Diagn, 2, 259, 10.1016/S1084-8592(97)80037-9

Hecimovic, 2001, A simple and rapid analysis of triplet repeat diseases by expand long PCR, Clin Chem Lab Med, 39, 1259, 10.1515/CCLM.2001.202

Houdayer, 1999, Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus, Clin Chem Lab Med, 37, 397, 10.1515/CCLM.1999.065

O'Connell, 2002, Standardization of PCR amplification for fragile X trinucleotide repeat measurements, Clin Genet, 61, 13, 10.1034/j.1399-0004.2002.610103.x

Saluto, 2005, An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene, J Mol Diagn, 7, 605, 10.1016/S1525-1578(10)60594-6

Strom, 2007, Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for fragile X syndrome, Genet Med, 9, 199, 10.1097/GIM.0b013e31803d3ac9

Fu, 1991, Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox, Cell, 67, 1047, 10.1016/0092-8674(91)90283-5

Baskaran, 1996, Uniform amplification of a mixture of deoxyribonucleic acids with varying GC content, Genome Res, 6, 633, 10.1101/gr.6.7.633

Kraff, 2007, Screen for excess FMR1 premutation alleles among males with parkinsonism, Arch Neurol, 64, 1002, 10.1001/archneur.64.7.1002

Warmer, 1996, A general method for the detection of large CAG repeat expansion by fluorescent PCR, J Med Genet, 33, 1022, 10.1136/jmg.33.12.1022